Chou said that a growing number of devices from resident firms have been adopted by prominent Taiwan medical institutions such as the affiliated hospitals of Kaohsiung Medical University and National Cheng Kung University (NCKU) in Tainan as well as Shuang Ho Hospital in New Taipei operated by Taipei Medical University. Tom Lee (李國宏), chief of the Investment Services Division, attributed this success to bureau initiatives aimed at promoting communication between manufacturers and practicing physicians. The MOST-overseen park bureau also operates assistance programs to help resident companies attend trade shows and build relationships with doctors in Southeast Asian markets like Malaysia, the Philippines, Thailand and Vietnam, he added.
In line with these efforts, an STSP medical device research and commercialization center was launched at the University of Medicine and Pharmacy in Ho Chi Minh City last November. The facility exhibits products from 13 resident firms and collaborates with the Medical Device Innovation Center at NCKU on product development.
The most significant recent step to promote international awareness of the nation’s biomedical expertise was the 2017 launch of the Taiwan Healthcare+ Expo. Organized by the IBMI, it is intended to serve as the most comprehensive trade show of its kind in Asia.
Staged Dec. 7-10 in Taipei, the inaugural edition featured about 1,050 booths by more than 300 local and foreign companies and medical centers, and attracted over 70,000 visitors and forum attendees. This year’s event, scheduled to run Nov. 29 to Dec. 2, is expected to be even bigger and will focus on highlighting smart health care solutions, according to Chien.
“The strength of the local information and communication technology sector gives Taiwan a major advantage in developing innovative biomedical products and services,” he said. “In addition to spotlighting this competitive edge, we aim to deepen cross-sector collaboration so that the latest breakthroughs in artificial intelligence, big data and robotics can benefit patients at home and around the world.”